Quietmind Foundation Publishes First Human Photobiomodulation Clinical Trial Findings

Quietmind Foundation's is pleased to announce pubication of the first in man research on the use of transcranial and intraocular 1068nm pulsed near infrared phototherapy effects on cognitive and behavioral symptoms of dementia was published in the April 2017 issue of Neurology and Neuroscience.

Quietmind is collaborating with Baylor, Scott & White Memorial Hospital's Dept. of Neurosurgery to expand on the subject sample and have modified the protocol so that all phototherapy sessions are conducted twice daily by the subject at home over the (30) day study period.  Additionally, subjects are being recruited nationally for a similar study for people with age related memory impairment and Parkinson's disease. Call 610-940-0488 for detaisl. 
(click to download the paper here nir_helmet_published_paper.pdf .